COYA

Coya Therapeutics
$4.27
+$0.01 (+0.35%)Jul 27, 2026
2.8FairMoatMint rating

MoatMint rates Coya Therapeutics (COYA) 2.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.3 out of 10.

Key metrics

The numbers that frame COYA today
Market cap
$100.04M
P/E (TTM)
-4.7
EV / FCF
-3.5
Gross margin
100%
EV / Sales
6.2
ROIC
1,962.9%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.71
52wk High
$7.75

COYA stock rating

How COYA scores on quality, value, growth, momentum and financial health
2.8out of 10
Fair overallFair business, expensive priceTop 72% of ~5,000 US stocks
QualityPoor1.3/10
GrowthGreat9.6/10
MomentumFair3.9/10
ValuePoor1.2/10
Financial HealthGood6.0/10

Growth

Revenue and earnings trend for COYA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about COYA
Is Coya Therapeutics a good buy?
No. Coya Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Coya Therapeutics is selling at a very high price.
What is the market capitalization of COYA?
Coya Therapeutics's market capitalization is $100.04M.
What is the P/E ratio for COYA stock?
Coya Therapeutics's current P/E ratio is -4.7.
What is the 52-week high for COYA stock?
The 52-week high for Coya Therapeutics is $7.75. The current close of $4.27 is 45% below that high.
What is the 52-week low for COYA stock?
The 52-week low for Coya Therapeutics is $3.71. The current close of $4.27 is 15% above that low.
Does COYA stock pay dividends?
Coya Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for COYA?
Coya Therapeutics's Debt / Equity ratio is 0.